GMED

GMED EBITDA Margin

30.07%TTM

Period ending:

GMED FY EBITDA Margin%
GMED FY EBITDA Margin40.59%16.47%
2009-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

GMED ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 17 observations from Dec 31, 2009 to Dec 31, 2025.

Globus Medical, Inc. Class A Common Stock EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
30.1726%
18.8034%
22.0968%
29.7703%
27.6301%
22.6029%
29.2204%
30.6485%
32.2947%
34.219%
35.9034%
33.6427%
27.8348%
34.3739%
34.9287%
36.6655%
38.2537%

Compare ebitda margin

All GMED financial metrics · GMED stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.